Ali Behbahani

Insider Reports History

Entity
Individual
Location
2855 Sand Hill Road, Menlo Park, CA
Signature
/s/ Zachary Bambach, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ali Behbahani:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Savara Inc 10%+ Owner Common Stock 24.5M $109M $4.45 Jul 17, 2023 Indirect
Korro Bio, Inc. Director, 10%+ Owner Common Stock 1.09M $61.1M $56.00 Apr 22, 2024 Indirect
Black Diamond Therapeutics, Inc. Director Common Stock 4.45M $11.1M $2.50 Dec 13, 2024 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Common Stock 949K $1.92M $2.02 Apr 11, 2022 Indirect
Metacrine, Inc. 10%+ Owner Common Stock 2.56M $1.2M $0.47 Dec 22, 2021 Indirect
Black Diamond Therapeutics, Inc. Director Common Stock 63.3K $158K $2.50 Dec 13, 2024 Direct
CVRx, Inc. Director Stock Option (right to buy) 27.3K $140K $5.14 Jun 4, 2024 Direct
MINERVA SURGICAL INC Director Common Stock 58.3K $11.9K $0.20 Jun 10, 2022 Direct
CVRx, Inc. Director Common Stock 316 $5.86K $18.55 Dec 14, 2023 Direct
Mirum Pharmaceuticals, Inc. 10%+ Owner Common Stock 135 $3.78K $28.04 Jun 13, 2023 Indirect
MBX Biosciences, Inc. 10%+ Owner Common Stock 3.61M Sep 16, 2024 Indirect
Trevi Therapeutics, Inc. 10%+ Owner Pre-Funded Warrants 3M Apr 11, 2022 Indirect
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 1.14M Jul 1, 2024 Direct
NeueHealth, Inc. 10%+ Owner Warrant (Right to Buy) 557K Oct 1, 2024 Indirect
Black Diamond Therapeutics, Inc. Director Stock Option (Right to Buy) 30.6K Jun 6, 2024 Direct
Nkarta, Inc. Director Stock Option (right to buy) 22.5K Jun 13, 2024 Direct
Monte Rosa Therapeutics, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 22.1K Jun 12, 2024 Direct
CRISPR Therapeutics AG Director Stock Option (Right to buy) 13K May 30, 2024 Direct
Arcellx, Inc. Director Stock Option (right to buy) 8.01K May 28, 2024 Direct
Korro Bio, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 5.19K Jun 11, 2024 Direct
Akouos, Inc. 10%+ Owner Common Stock 0 $12.50 Nov 30, 2022 Indirect
GENOCEA BIOSCIENCES, INC. Director, 10%+ Owner Common Stock 0 $1.25 May 25, 2022 Indirect
MBX Biosciences, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 Sep 16, 2024 Indirect
MBX Biosciences, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 Sep 16, 2024 Indirect
Oyster Point Pharma, Inc. Director Common Stock 0 $11.20 Jan 3, 2023 Direct
Oyster Point Pharma, Inc. Director Stock Option (Right to Buy) 0 Jan 3, 2023 Direct

Insider Reports Filed by Ali Behbahani

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BDTX Black Diamond Therapeutics, Inc. Dec 13, 2024 1 $14.4K 4 Dec 16, 2024 Director
NEUE NeueHealth, Inc. Oct 1, 2024 3 $0 4 Oct 3, 2024 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Sep 20, 2024 1 $14.4K 4 Sep 20, 2024 Director
MBX MBX Biosciences, Inc. Sep 16, 2024 5 $8M 4 Sep 17, 2024 10%+ Owner
MBX MBX Biosciences, Inc. Sep 12, 2024 0 $0 3 Sep 12, 2024 10%+ Owner
ADAP Adaptimmune Therapeutics PLC Jul 1, 2024 1 $0 4 Jul 1, 2024 Director
BDTX Black Diamond Therapeutics, Inc. Jun 21, 2024 1 $14.4K 4 Jun 21, 2024 Director
NKTX Nkarta, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 12, 2024 1 $0 4 Jun 13, 2024 Director, 10%+ Owner
KRRO Korro Bio, Inc. Jun 11, 2024 1 $0 4 Jun 12, 2024 Director, 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Jun 6, 2024 1 $0 4 Jun 6, 2024 Director
CVRX CVRx, Inc. Jun 4, 2024 1 $0 4/A Jun 7, 2024 Director
CVRX CVRx, Inc. Jun 4, 2024 1 $0 4 Jun 6, 2024 Director
CRSP CRISPR Therapeutics AG May 30, 2024 1 $0 4 May 31, 2024 Director
ACLX Arcellx, Inc. May 28, 2024 1 $0 4 Jun 6, 2024 Director
KRRO Korro Bio, Inc. Apr 22, 2024 1 $1M 4 Apr 24, 2024 Director, 10%+ Owner
NEUE NeueHealth, Inc. Apr 8, 2024 3 $0 4 Apr 10, 2024 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Mar 15, 2024 1 $14.4K 4 Apr 3, 2024 Director
ADAP Adaptimmune Therapeutics PLC Jan 15, 2024 1 $0 4 Jan 17, 2024 Director
BHG Bright Health Group Inc. Dec 19, 2023 1 $0 4 Dec 21, 2023 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Dec 15, 2023 1 $12.2K 4 Dec 15, 2023 Director
CVRX CVRx, Inc. Dec 14, 2023 2 $74.90 4 Dec 18, 2023 Director
FREQ Korro Bio, Inc. Nov 3, 2023 2 $0 4 Nov 7, 2023 Director, 10%+ Owner
FREQ Korro Bio, Inc. Nov 3, 2023 0 $0 3 Nov 7, 2023 Director
BHG Bright Health Group Inc. Oct 31, 2023 1 $0 4 Nov 2, 2023 10%+ Owner
BHG Bright Health Group Inc. Sep 15, 2023 1 $0 4 Sep 19, 2023 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Sep 15, 2023 1 $11.9K 4 Sep 18, 2023 Director
BHG Bright Health Group Inc. Aug 11, 2023 1 $0 4 Aug 15, 2023 10%+ Owner
SVRA Savara Inc Jul 17, 2023 1 $1M 4 Jul 19, 2023 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Jul 5, 2023 1 $5M 4 Jul 6, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jul 3, 2023 1 $0 4 Jul 3, 2023 Director
BDTX Black Diamond Therapeutics, Inc. Jun 16, 2023 1 $11.9K 4 Jun 16, 2023 Director
ACLX Arcellx, Inc. Jun 14, 2023 1 $0 4 Jun 16, 2023 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director, 10%+ Owner
MIRM Mirum Pharmaceuticals, Inc. Jun 13, 2023 4 $0 4 Jun 15, 2023 10%+ Owner
CRSP CRISPR Therapeutics AG Jun 8, 2023 1 $0 4 Jun 9, 2023 Director
NKTX Nkarta, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
CVRX CVRx, Inc. Jun 5, 2023 1 $0 4 Jun 7, 2023 Director
ACLX Arcellx, Inc. Jun 1, 2023 2 $0 4 Jun 5, 2023 Director
BDTX Black Diamond Therapeutics, Inc. May 16, 2023 1 $0 4 May 17, 2023 Director
BDTX Black Diamond Therapeutics, Inc. Mar 16, 2023 1 $11.9K 4 Mar 20, 2023 Director
OYST Oyster Point Pharma, Inc. Jan 3, 2023 4 $0 4 Jan 4, 2023 Director
ACLX Arcellx, Inc. Dec 20, 2022 2 $0 4 Dec 22, 2022 Director
BDTX Black Diamond Therapeutics, Inc. Dec 16, 2022 1 $11.9K 4 Dec 19, 2022 Director
AKUS Akouos, Inc. Nov 30, 2022 1 $0 4 Dec 2, 2022 10%+ Owner
BHG Bright Health Group Inc. Oct 17, 2022 2 $138M 4 Oct 19, 2022 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Sep 16, 2022 1 $11.9K 4 Sep 19, 2022 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2022 1 $0 4 Jul 1, 2022 Director
BDTX Black Diamond Therapeutics, Inc. Jun 17, 2022 1 $11.9K 4 Jun 17, 2022 Director
GLUE Monte Rosa Therapeutics, Inc. Jun 15, 2022 1 $0 4 Jun 16, 2022 Director, 10%+ Owner
UTRS MINERVA SURGICAL INC Jun 10, 2022 1 $120K 4 Jun 14, 2022 Director
BDTX Black Diamond Therapeutics, Inc. Jun 10, 2022 1 $0 4 Jun 13, 2022 Director
CRSP CRISPR Therapeutics AG Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
NKTX Nkarta, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
CVRX CVRx, Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
OYST Oyster Point Pharma, Inc. Jun 6, 2022 2 $0 4 Jun 8, 2022 Director
GNCA GENOCEA BIOSCIENCES, INC. May 24, 2022 2 -$751K 4 May 26, 2022 Director, 10%+ Owner
TRVI Trevi Therapeutics, Inc. Apr 11, 2022 3 $12.5M 4 Apr 13, 2022 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Mar 18, 2022 1 $13.1K 4 Mar 18, 2022 Director
ACLX Arcellx, Inc. Feb 3, 2022 0 $0 3 Feb 3, 2022 Director
BHG Bright Health Group Inc. Jan 3, 2022 2 $200M 4 Jan 5, 2022 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Dec 17, 2021 1 $13.1K 4 Dec 17, 2021 Director
MTCR Metacrine, Inc. Dec 10, 2021 3 -$494K 4 Dec 27, 2021 10%+ Owner
UTRS MINERVA SURGICAL INC Oct 26, 2021 20 -$37.4K 4 Oct 28, 2021 Director
UTRS MINERVA SURGICAL INC Oct 21, 2021 0 $0 3 Oct 21, 2021 Director
TRVI Trevi Therapeutics, Inc. Oct 18, 2021 3 $0 4 Oct 19, 2021 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Sep 17, 2021 1 $13.1K 4 Sep 23, 2021 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
GNCA GENOCEA BIOSCIENCES, INC. Jul 1, 2021 1 $0 4 Jul 2, 2021 Director, 10%+ Owner
CVRX CVRx, Inc. Jun 29, 2021 1 $0 4 Jul 1, 2021 Director
CVRX CVRx, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Director
BHG Bright Health Group Inc. Jun 28, 2021 12 $35M 4 Jun 30, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 28, 2021 7 $20M 4 Jun 30, 2021 Director, 10%+ Owner
BHG Bright Health Group Inc. Jun 24, 2021 0 $0 3 Jun 24, 2021 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 1 $0 4 Jun 25, 2021 Director, 10%+ Owner
GLUE Monte Rosa Therapeutics, Inc. Jun 23, 2021 0 $0 3 Jun 23, 2021 Director, 10%+ Owner
BDTX Black Diamond Therapeutics, Inc. Jun 18, 2021 2 $13.1K 4 Jun 22, 2021 Director
NKTX Nkarta, Inc. Jun 13, 2021 1 $0 4 Jun 15, 2021 Director
CRSP CRISPR Therapeutics AG Jun 10, 2021 1 $0 4 Jun 14, 2021 Director
OYST Oyster Point Pharma, Inc. Jun 7, 2021 2 $0 4 Jun 9, 2021 Director